Literature DB >> 12450217

alphaNAC requires an interaction with c-Jun to exert its transcriptional coactivation.

Isabelle Quèlo1, Mélanie Hurtubise, René St-Arnaud.   

Abstract

alphaNAC is a transcriptional coactivator known to interact with the N-terminal activation domain of the c-Jun transcription factor. In this article, we describe the identification of the c-Jun interaction domain within the alphaNAC protein. Deletion analysis of alphaNAC indicated that the c-Jun binding site was located in the middle part of the protein, between residues 89 and 129. The deletion of the C-terminal end of alphaNAC, including the c-Jun interacting domain, induced a nuclear translocation of the mutated coactivator. Despite its presence in the nucleus, this deletion mutant did not retain the capacity to coactivate an AP-1 response. These results demonstrate that the interaction between alphaNAC and c-Jun was necessary for the potentiation of theAP-1 transcriptional activity. These data are consistent with a mechanism by which alphaNAC acts as a coactivator for c-Jun-dependent transcription by interacting with the c-Jun N-terminal activation domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450217      PMCID: PMC5977523          DOI: 10.3727/000000002783992433

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  28 in total

Review 1.  Transport between the cell nucleus and the cytoplasm.

Authors:  D Görlich; U Kutay
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

Review 2.  Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity.

Authors:  Y Chinenov; T K Kerppola
Journal:  Oncogene       Date:  2001-04-30       Impact factor: 9.867

3.  Differential splicing-in of a proline-rich exon converts alphaNAC into a muscle-specific transcription factor.

Authors:  W V Yotov; R St-Arnaud
Journal:  Genes Dev       Date:  1996-07-15       Impact factor: 11.361

4.  TAFII250 is a bipartite protein kinase that phosphorylates the base transcription factor RAP74.

Authors:  R Dikstein; S Ruppert; R Tjian
Journal:  Cell       Date:  1996-03-08       Impact factor: 41.582

5.  Avian sarcoma virus 17 carries the jun oncogene.

Authors:  Y Maki; T J Bos; C Davis; M Starbuck; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

6.  Activating protein-1, nuclear factor-kappaB, and serum response factor as novel target molecules of the cancer-amplified transcription coactivator ASC-2.

Authors:  S K Lee; S Y Na; S Y Jung; J E Choi; B H Jhun; J Cheong; P S Meltzer; Y C Lee; J W Lee
Journal:  Mol Endocrinol       Date:  2000-06

7.  Drosophila TAFII150: similarity to yeast gene TSM-1 and specific binding to core promoter DNA.

Authors:  C P Verrijzer; K Yokomori; J L Chen; R Tjian
Journal:  Science       Date:  1994-05-13       Impact factor: 47.728

8.  Yeast BTF3 protein is encoded by duplicated genes and inhibits the expression of some genes in vivo.

Authors:  G Z Hu; H Ronne
Journal:  Nucleic Acids Res       Date:  1994-07-25       Impact factor: 16.971

9.  Activation of cAMP and mitogen responsive genes relies on a common nuclear factor.

Authors:  J Arias; A S Alberts; P Brindle; F X Claret; T Smeal; M Karin; J Feramisco; M Montminy
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

10.  CBP-induced stimulation of c-Fos activity is abrogated by E1A.

Authors:  A J Bannister; T Kouzarides
Journal:  EMBO J       Date:  1995-10-02       Impact factor: 11.598

View more
  10 in total

1.  Sequence-specific DNA binding by the alphaNAC coactivator is required for potentiation of c-Jun-dependent transcription of the osteocalcin gene.

Authors:  Omar Akhouayri; Isabelle Quélo; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

2.  Nuclear alpha NAC influences bone matrix mineralization and osteoblast maturation in vivo.

Authors:  Thomas Meury; Omar Akhouayri; Toghrul Jafarov; Vice Mandic; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

3.  Dephosphorylation of the transcriptional cofactor NACA by the PP1A phosphatase enhances cJUN transcriptional activity and osteoblast differentiation.

Authors:  William N Addison; Martin Pellicelli; René St-Arnaud
Journal:  J Biol Chem       Date:  2019-04-04       Impact factor: 5.157

Review 4.  Combinatorial control of ATF4-dependent gene transcription in osteoblasts.

Authors:  René St-Arnaud; Bahareh Hekmatnejad
Journal:  Ann N Y Acad Sci       Date:  2011-11       Impact factor: 5.691

5.  Casein kinase II phosphorylation regulates alphaNAC subcellular localization and transcriptional coactivating activity.

Authors:  Isabelle Quélo; Claude Gauthier; René St-Arnaud
Journal:  Gene Expr       Date:  2005

6.  The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass.

Authors:  Martin Pellicelli; Julie A Miller; Alice Arabian; Claude Gauthier; Omar Akhouayri; Joy Y Wu; Henry M Kronenberg; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

7.  Ribosome association and stability of the nascent polypeptide-associated complex is dependent upon its own ubiquitination.

Authors:  Olesya O Panasenko; Fabrice P A David; Martine A Collart
Journal:  Genetics       Date:  2008-12-15       Impact factor: 4.562

8.  FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice.

Authors:  Vionnie W C Yu; Gourgen Ambartsoumian; Lieve Verlinden; Janet M Moir; Josée Prud'homme; Claude Gauthier; Peter J Roughley; René St-Arnaud
Journal:  J Cell Biol       Date:  2005-05-23       Impact factor: 10.539

9.  Ubiquitin specific peptidase Usp53 regulates osteoblast versus adipocyte lineage commitment.

Authors:  Hadla Hariri; William N Addison; René St-Arnaud
Journal:  Sci Rep       Date:  2021-04-19       Impact factor: 4.379

Review 10.  Fidelity of Cotranslational Protein Targeting to the Endoplasmic Reticulum.

Authors:  Hao-Hsuan Hsieh; Shu-Ou Shan
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.